Javier A. Adachi, M.D., FACP, FIDSA
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Deputy Chair, Clinical Programs, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Member, UT Center for Antimicrobial Resistance and Microbial Genomics, UT Health Science Center McGovern Medical School, Houston, TX
Member, National School of Tropical Medicine, Department of Infectious Diseases, Infection Control and Employee Health, Baylor College of Medicine, Houston, TX
Adjunct Professor, Department of Medicine, Baylor College of Medicine, Houston, TX
Adjunct Professor, Department of Epidemiology, Human Genetics & Environmental Sciences, The University of Texas School of Public Health, Houston, TX
Clinical Adjunct Professor, Department of Medicine, The University of Texas Health Science Center at Houston Medical School, Houston, TX
Adjunct Clinical Professor, Department of Internal Medicine, Texas A&M Health Science Center, Houston, TX
Dual/Joint/Adjunct Appointment
Facilitator, Blood Culture Diagnostic Stewardship, Dr. Eduardo Yepez,, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Facilitator, Infectious Diseases Deposition Program, Dr. Eduardo Yepez,, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Deputy Chair, Clinical Programs, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Facilitator, Improving Diagnostic Stewardship, Dr. Teny John, Department of Infectious Diseases, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Facilitator-Division of Internal Medicine-APP Onboarding Project, Shannon Holloway, Department of Infectious Diseases, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Advance Provider Practitioner's in Infectious Diseases Department, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Facilitator, Sponsor Implementing Outpatient Follow-ups for Hematology Malignant Patients with COVID, Dr. Fareed Khawaja, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Member, UT Center for Antimicrobial Resistance and Microbial Genomics, UT Health Science Center McGovern Medical School, Houston, TX
Member, National School of Tropical Medicine, Department of Infectious Diseases, Infection Control and Employee Health, Baylor College of Medicine, Houston, TX
Clinical Adjunct Professor, Department of Medicine, The University of Texas Health Science Center at Houston Medical School, Houston, TX
Adjunct Professor, Department of Medicine, Baylor College of Medicine, Houston, TX
Adjunct Professor, Department of Epidemiology, Human Genetics & Environmental Sciences, The University of Texas School of Public Health, Houston, TX
Adjunct Clinical Professor, Department of Internal Medicine, Texas A&M Health Science Center, Houston, TX
Research Member, Center for Infectious Diseases, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX
Research Member, Department of Clinical Laboratory, Carlos Carrillo E.I.R.L, Lima
Adjunct Assistant Professor, Department of Academic Department of Medicine and Academic Department of Microbiology, Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia, Lima
Education & Training
Degree-Granting Education
| 1992 | Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia, Lima, US, MD |
Postgraduate Training
| 2006-2007 | Clinical Safety & Effectiveness Education Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1996-2000 | Fellowship, Division of Infectious Diseases, The University of Texas Health Science Center at Houston Medical School, Houston, Texas |
| 1996-2000 | Research Fellowship, Center for Infectious Diseases, The University of Texas Health Science Center at Houston Medical School and School of Public Health, Houston, Texas |
| 1993-1996 | Residency Program, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan |
Licenses & Certifications
| 2025 | Tennessee Board of Medical Examiners |
| 2025 | Georgia Composite Medical Board |
| 2025 | Arizona Board of Medical Examiners |
| 2025 | Alabama Board of Medical Examiners |
| 2025 | Florida Board of Medicine |
| 2025 | Oklahoma State Board |
| 2024 | Washington State Department of Health |
| 2024 | Louisiana State Board of Medical Examiners |
| 2024 | Mississippi State Board of Medical Licensure |
| 2014 | American Board of Medical Quality - Certified in Medical Quality |
| 2009 | American Board of Internal Medicine - Infectious Disease Subspecialty Board |
| 2006 | American Board of Internal Medicine - Internal Medicine Specialty Board |
| 2005 | Texas Medical License |
| 1992 | Peruvian Medical License |
Experience & Service
Faculty Academic Appointments
Vice-Chair, Ad Interim, Clinical Programs Department, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023
Facilitator, Sponsor Improving Telemedicine in Infectious Diseases Clinic, Dr. Amy Spallone CS&E Department of Infectious Diseases, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2022
Associate Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2016
Adjunct Assistant Professor, Department of Medicine, Baylor College of Medicine, Houston, TX, 2009 - 2010
Adjunct Assistant Professor, Department of Epidemiology, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, 2007 - 2010
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2010
Clinical Adjunct Assistant Professor, Department of Medicine, The University of Texas Health Science Center at Houston Medical School, Houston, TX, 2000 - 2010
Clinical Instructor, Department of Physical Diagnosis Course, The University of Texas Health Science Center at Houston Medical School, Houston, TX, 1997 - 1999
Clinical / Research Preceptor, Department of Summer Senior Elective Rotation in Infectious Diseases, Guadalajara, Mexico, The University of Texas Health Science Center at Houston Medical School, Houston, TX, 1997 - 1999
Instructor, Department of Medical Microbiology Course Seminars, The University of Texas Health Science Center at Houston Medical School, Houston, TX, 1997 - 2000
Research Assistant, Department of Infectious Diseases Research Laboratory, Division of Infectious Diseases, Henry Ford Hospital, Detroit, MI, 1994 - 1996
Research Assistant, Department of Laboratory of Clinical Microbiology, Academic Department of Microbiology, Tropical Medicine Institute, Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, 1988 - 1993
Teacher Assistant, Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia, Lima, 1986 - 1992
Administrative Appointments/Responsibilities
Facilitator, Blood Culture Diagnostic Stewardship, Dr. Eduardo Yepez,, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Facilitator, Infectious Diseases Deposition Program, Dr. Eduardo Yepez,, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Deputy Chair, Clinical Programs, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Facilitator, Improving Diagnostic Stewardship, Dr. Teny John, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Facilitator - Division of Internal Medicine - APP Onboarding Project, Shannon Holloway, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Alternate Chair, Infection Control Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Member, COVID-19 Multi-disciplinary Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Alternate Member, COVID-19 Vaccine Command Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Member, COVID-19 Algorithm Task Force, Department of Academic Affairs, Sr VP Office, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Member, COVID-19 Service Work Flow Task Force, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Alternate Member, COVID-19 Core Leadership Team, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Member, Clinical Competency Committee, Infectious Diseases Fellowship Program The University of Texas MD Anderson Cancer Center and UTHSC-McGovern Medical School, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Chair, Session on Infectious Diseases in Cancer, Global Academic Program Annual Conference, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Member, Subcommittee to Develop a New Score System for Faculty Promotion, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Member, Subcommittee to Review the inclusion of Areas of Service of Excellence in Faculty Promotions, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Member, Department of Operations CTe, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Member, Organizing Committee, Fourth Infections in Cancer Symposium, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2020
Member, The University of Texas MD Anderson Cancer Center Global Academic Program Faculty Organizing Committee, The University of MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Member, Departmental Faculty Leadership Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Facilitator, Improving Delivery of Outpatient Parenteral Antimicrobial Therapy, Dr. Natalie Dailey-Garnes, CS&E, Dept. of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Clinical Service Director, Infectious Diseases-Leukemia Department, Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Co-chair, Session on Infectious Diseases in Cancer, GAP Annual Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Elected member, PRS Executive Council, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Facilitator, Resolving Penicllin Allergy, Dr. Mahnaz Taremi, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Co-chair, Session on Infectious Diseases in Cancer, Global Academic Program Annual Conference, The University of Texas MD Anderson Cancer Center, Sao Paulo, 2016 - Present
Member, Faculty Scholarly Mentoring Committee, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Vice-Chair, Institutional Research Grant Clinical Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2017
Co-chair, Session on Infectious Diseases in Cancer, Global Academic Program Annual Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present
Facilitator, Improving the Outcome of Cancer Patients with complicated UTI in the presence of Urinery Devices. Ariel Szvalb, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present
Member, Regent's Outstanding Teaching Awards, Nomination Advisory Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Facilitator, Improving the outcomes of Cancer Patients with CLABSI, Anne-Marie Chaftari, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Facilitator, Minimize duration of GPC Therapy in leukemia, Frank Tverdek's Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Co-Chair, Session on Infectious Diseases in Cancer, Global Academic Program Conference, The University of Texas MD Anderson Cancer Center, Seoul, 2014 - Present
Member, Institutional Research Grant Oversight Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Member, Faculty Achievements Award Selection Committee, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Chair, Institutional Research Grant Clinical Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2014
Co-Chair, Session on Infectious Diseases in Cancer, Global Academic Program Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Facilitator, Improving Post-Stem Cell Transplant Vaccination Administration, Dr. Ella Ariza's Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2015
Facilitator, Breast Tissue Expander ID Clinic, Dr. George Viola's Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Member, Clinical Research Advisory Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2017
Facilitator, CSR Efficiency, Mark Tansiongco's Team, CS&E, Internal Medicine Clinic, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2015
Member, Faculty Senate, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2015
Member, Organizing Committee, Third Infections in Cancer Symposium, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Facilitator, Improving the Outcomes of Patients with Staphylococcus Aureus Bloodstream Infections, Dr. Shelburne's Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2014
Facilitator, Improving the Outcomes of Patients with Multidrug-Resistant Gram Negative Rods Bloodstream Infections, Dr. El Zakhem's Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
EHR Champion, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2014
Vice-Chair, Institutional Research Grant Clinical Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Member, Steering Committee Residency Program, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present
Coordinator, Development of Infectious Diseases Outpatient Clinic Service Dedicated to the Screening, Care and Prevention of Bloodstream Infections in Cancer Patients, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present
Member, Study Section Research Committee for Sister Institution Network Fund Project, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present
Coordinator, Development of Infectious Diseases Outpatient Clinic Service Dedicated to the Screening, Care and Prevention of Cancer Patients with Chronic Diarrhea, Department of In Collaboration with the Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present
Co-Coordinator, Development of ID Outpatient Consult Service dedicated to the screening and care of infections and problems with international patients coming to MDACC for chemotherapy treatment or stem cell transplantation, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present
Co-Chairman, Department of Division of Internal Medicine Grand Rounds Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2011
Facilitator, Improvement on Consult Process, Dr. Granwehr's Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2014
Facilitator, Development of Hepatitis C Clinic, Dr. Torres' Team, CS&E, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2014
Member, Actualization of Consultation Policy Task Force, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present
Team Co-Leader, Multidisciplinary Antimicrobial Stewardship Team, Quality Improvement & Clinical Safety & Effectiveness, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2009
Facilitator, Same Day Consults in ID Clinic Project, Dr. Mulanovich's Team, CS&E Session 7, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2008
Associate Director, Infectious Diseases Fellowship Program, The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, TX, 2007 - 2011
Chairman, Department of Division of Internal Medicine Grand Rounds Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2010
Coordinator, Development of new joint ID Fellowship Program with Baylor College of Medicine (with Dr. Tweardy): Submission of the documents and site visit of the joint program by ACGME and all clinical and academic activities, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2009
Coordinator, Renewal of the T-32 Training Grant with Baylor College of Medicine: Preparation and submission of required documents (with Dr. Tweardy), Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2009
Co-Chairman, CME Weekly Infectious Diseases Case Review, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Present
Conference Coordinator, Second Infections in Cancer Symposium, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2008
Team Leader, Multidisciplinary Antimicrobial Stewardship Team, Quality Improvement & Clinical Safety & Effectiveness, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2007
Project Leader, MAST Project in ICU - CS&E Session 4, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2007
Associate Director, Infectious Diseases Fellowship Program, The University of Texas MD Anderson Cancer Center & University of Texas Medical Health Science Center at Houston Medical School, Houston, TX, 2005 - 2011
Director of Academic Training Programs, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2011
Conference Coordinator, First Infections in Cancer Symposium, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2008
Special Assistant of Dr. Herbert DuPont, Governor of South Texas Chapter, American College of Physicians, Houston, TX, 2004 - 2007
Special Assistant of Academic and Clinical Programs for Dr. Issam Raad, Chief, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - Present
Co-Director of the academic exchange program for medical students between Henry Ford Hospital and Universidad Peruana Cayetano Heredia, Lima-Peru, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, 1994 - 1996
Member, Committee for selection of Peruvian medical doctors applying for the residency program in Internal Medicine, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, 1994 - 1996
Student Member, Committee for modification of the academic curriculum, Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia, Lima, 1994 - 1996
Student Member of the Faculty Council, highest executive board, Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia, Lima, 1989 - 1991
Student Member of the University Assembly, highest executive board, Universidad Peruana Cayetano Heredia, Lima, 1988 - 1989
Other Professional Positions
Advisor, Sistership Institute Project between MDACC and AUNA-Oncosalud, Lima, 2013 - Present
Co-Author, Quality Improvement Effort for Maintenance of Certification for Medical Specialties, Office of the Vice President of Medical Affairs, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Member, Review Board, 2013 DoIM Employee Excellence Awards-General Administration, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Advisor, Stem Cell Transplantation in Pediatric Patients Project between MDACC and INEN, Lima, 2013 - Present
Trainee Research Day 2012 Reviewer/ Judge, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012
Trainee Research Day 2011 Reviewer/Judge, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011
Advisor, Development of Research Collaborative Projects between The University of Texas MD Anderson Cancer Center and "Instituto Nacional de Enfermedades Neoplasicas", Lima, 2011 - Present
Trainee Research Day 2010 Reviewer/Judge, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010
Advisor, Sistership Institute Project between MDACC and "Instituto Nacional de Enfermedades Neoplasicas" (Peruvian National Cancer Institute), Lima, 2009 - 2011
Clinical Preceptor, Physical Diagnosis Course, The University of Texas Health Science Center at Houston Medical School, Houston, TX, 2007 - Present
Member of the Peruvian Study Group of Infectious Diarrhea in Cancer, Peruvian National Cancer Institute, Lima, 2007 - Present
Vice-President, Education Committee, Peruvian American Medical Society, Lima, 2006 - 2007
Member of the Steering Committee, Infections in Cancer Group, Houston, TX, 2005 - Present
Research Advisor, National Institutes of Health of Peru, Lima, 1992 - 1998
Extramural Institutional Committee Activities
Member, Task for To Improve Utilization of Blood Cultures, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Subcommittee to Review the Inclusion of Areas of Service of Excellence in Faculty Promotions, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Subcommittee to Develop a New Score System for Faculty Promotion, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2020
Vice-Chair, Institutional Research Grant Clinical Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2017
Member, PRS Executive Council, The University of Texas MD Anderson Cancer Center, 2016 - 2020
Member, Faculty Achievements Award Selection Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Regent's Outstanding Teaching Awards 2014-2015, Nomination Advisory Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Co-Chair, Institutional Research Grant Oversight Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Chair, Institutional Research Grant Clinical Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Member, Clinical Research Advisory Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Member, Clinical Research Committee 4, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Alternate, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Member, Acute and Critical Care Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2017
Member, Department of Infectious Diseases, Infection Control Employee Health, Chair, Selection Advisory Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2023
Vice-Chair, Institutional Research Grant Clinical Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2013
Member, Study Section Review Committee for Cancer Prevention Research Seed Funding Program, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Study Section Research Committee for Sister Institution Network Fund Project, The University of Texas MD Anderson Cancer Center, 2011 - Present
Member, Study Section Review Committee for Clinical Translational and Population-Based Research Projects under the Institutional Research Grants Program, The University of Texas MD Anderson Cancer Center, 2011 - Present
Alternate, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2010 - 2014
Co-Chair, Division of Internal Medicine Grand Rounds Steering Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Actualization of Consultation Policy Task Force, The University of Texas MD Anderson Cancer Center, 2010 - Present
Member, Quality Improvement Oversight Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2011
Member, Clinic Research Committee 4, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Chair, Division of Internal Medicine Grand Rounds Steering Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2010
Alternate, Internal Medicine Clinic (IMC) Steering Committee, The University of Texas MD Anderson Cancer Center, 2006 - Present
Member, Budget Subcommittee, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2012
Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2012
Member, Intensive Care Unit Subcommittee, The University of Texas MD Anderson Cancer Center, 2004 - 2012
Member, Guidelines for Adult ICU Severe Sepsis Group, The University of Texas MD Anderson Cancer Center, 2004 - 2014
Member, Clinical Research Committee 3, The University of Texas MD Anderson Cancer Center, 2004 - 2008
Member, Antibiotic Task Force, The University of Texas MD Anderson Cancer Center, 2004 - 2014
Member, Infection Control Committee, The University of Texas MD Anderson Cancer Center, 2003 - Present
Member, Infection Control Core Group, The University of Texas MD Anderson Cancer Center, 2003 - Present
Honors & Awards
| 2024 | Clinical Faculty Teacher Award,, Infectious Diseases, Infection Control and Employee Health |
| 2023 | Teacher of the Year, Infectious Diseases Fellows, Baylor College of Medicine |
| 2019 | IDSA Travel Grant Winner (Mentor) for Dr. Aki Sakurai (Fellow in Training) "Impact of Early Fiberoptic Bronchoscopy on Microbiological Diagnostic Rate and Clinical Outcomes of Pneumonia in Acute Leukemia patients", 57th Annual Meeting of the IDSA, Washington DC |
| 2019 | Teacher of the Year, Infectious Diseases Fellows, Baylor College of Medicine |
| 2018 | Finalist (Mentor) for Dr. Mahnaz Taremi, Clinical Research Project Cyrus Scholar Award, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center |
| 2018 | IDSA Travel Grant Winner (Mentor) for Dr. Aki Sakurai (Fellow in Training) "Effective and Early Diagnosis of Pneumonia in Patients with Acute Leukemia in a Comprehensive Cancer Center: How can we improve the microbiological diagnosis?, 56th Annual Meeting of the IDSA, San Francisco, CA |
| 2018 | IDSA Travel Grant Winner (Mentor) for Dr. Emma Dischner (Fellow in Training) "Infectious Diseases (ID) Complications in Immunocompromised (IC) Patients with Cancer Post-Hurricane Harvey at a Comprehensive Cancer Center in 2017", 56th Annual Meeting of the IDSA, San Francisco, CA |
| 2017 - 2023 | DoIM, Research and Quality Improvement Development Awards (Mentor) for Dr. Mahnaz Taremi, "Implantation of penicillin allergy skin test in immunocompromised cancer patients" |
| 2017 | Teacher of The Year, Infectious Diseases Fellows, Baylor College of Medicine |
| 2016 | Recognition for Plan Project, "Improving Outcomes of Hematological Malignancy Patients with Vancomycin-Resistant Enterococcus Bloodstream Infections" Office of Performance Improvement, The University of Texas MD Anderson Cancer Center |
| 2015 | Celebrating Improvement at MD Anderson Recognition for Act++ Project, Improving the Outcomes of Patients with Multidrug-Resistant Gram Negative Rod Bloodstream Infection, The Office of Performance Improvement, The University of Texas MD Anderson Cancer Center |
| 2015 | Winner, ASM ICAAC Infectious Diseases Fellows Grant Winner (Mentor) for Dr. Nobuyoshi Mori "Multidrug-Resistant Gram Negative Rods Bloodstream Infections in Cancer Patients",, ICAAC/ICC 2015, San Diego, CA, 2015 |
| 2015 | Winner, Clinical Innovator Award, The University of Texas MD Anderson Cancer Center |
| 2015 | Winner, NCI Supplement Grant, "Study of the Vaginal Microbiota in HIV/HPV Patients with Cervical Dysplasia and Cancer", MDACC and Botswana National Cancer Institute, Houston, TX 2015 |
| 2014 | 3rd place, Sustained CS&E Project, "Sustained Improvement in the Outcomes of Patients with MDR-GNR BSI (2012-2014)", Shared Visions: Improving Systems to Improve Lives Conference, The University of Texas System |
| 2014 | First Place, for Post-Doctoral Presentation, (Mentor) for Lorenzo D'Amico, PhD (Post-Doc) "Microfluids isolation and detection of bacteria for metagenomic analysis and clinical diagnostics", Molecular Virology and Microbiology Retreat |
| 2014 | IDSA Travel Grant Winner (Mentor) for Dr. Nobuyoshi, Mori (Fellow in Training) "Infectious Myositis Secondary to Multidrug-Resistant Gram Negative Rods in Cancer Patients", 52th Annual Meeting of The IDSA, Philadelphia, PA |
| 2014 | Recognition for Act & Sustain QI Project, "Improving the Outcomes of Patients with MDR-GNR BSI" Office of Performance Improvement,The University of MD Anderson Cancer Center |
| 2014 | Winner, Regent's Outstanding Teaching Award, The University of Texas System |
| 2014 | Winner, Sister Institutions Network Fund (SINF) Resanciesearch Grant Award, MDACC, "Genomic characteristics of VRE BSI in patients with hematological malign: impact on clinical outcomes in 6 geographical regions", Sister Institutions Network Fund |
| 2013 - 2014 | Chair, Study Section Review Committee for Clinical Translational and Population-Based Research Projects under the Institutional Research Grants Program, The University of Texas MD Anderson Cancer Center |
| 2013 | Fellow of the University of Texas System Clinical Safety and Effectiveness, The University of Texas MD Anderson Cancer Center |
| 2013 | IDSA Travel Grant Winner (Mentor) for Dr. Nobuyoshi, Mori (Fellow in Training) Abstract Title "Improving the outcomes of patients with MDR-GNR BSI", 51st Annual Meeting of the IDSA, San Francisco, CA |
| 2013 | Recognition for Act & Sustain QI Project, "Improving the Outcomes of Patients with MDR-GNR BSI" Office of Performance Improvement, The University of MD Anderson Cancer Center |
| 2013 | Recognition for Act & Sustain QI Project, "Improving the Outcomes of Patients with Staphylococcus aureus BSI" Office of Performance Improvement, The University of MD Anderson Cancer Center |
| 2013 | Second Place, TIDS research awards (mentor) for Dr. Aline El Zakhem(Fellow in Training), Abstract title "Improving the outcomes of patients with MDR-GNR BSI", Texas Infections Diseases Society Annual Meeting, San Antonio |
| 2013 | Teacher of The Year, Infectious Diseases Fellows, The University of Texas Health Science Center at Houston |
| 2013 | Winner, Clinical Research Project, Cyrus Scholar Award, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center |
| 2012 | Winner, Leadership in Education Award, The University of Texas MD Anderson Cancer Center, Division of Internal Medicine |
| 2012 - 2013 | Vice-Chair, Study Section Review Committee for Clinical Translational and Population-Based Research Projects under the Institutional Research Grants Program, The University of Texas MD Anderson Cancer Center |
| 2012 | IDSA Travel Grant Winner (Mentor) for Dr. Nobuyoshi Mori (Fellow in Training), Abstract title "Increasing Rates of Multi-Drug Resistant Organism Bloodstream Infections in a Comprehensive Cancer Center: Rifaximin as a Novel Alternative for Antimicrobial Prophylaxis", 50th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA |
| 2011 | IDSA Travel Grant Winner (Mentor) for Dr. Jorge Zuniga (Fellow in training), Abstract title, "Neutropenic Enterocolitis Complicating Taxane-Based Chemotherapy in Cancer Patients", 49th Annual Meeting of the Infectious Diseases Society of America, Boston, MA |
| 2011 | Winner, Sister Institution Network Fund (SINF) Research Grant Award, The University of Texas MD Anderson Cancer Center Project, Identification of the gastro-intestinal microbiota in patients with leukemia at MD Anderson Cancer Center, Houston, Texas and at "Instituto Nacional de Enfermedades Neoplastics," Peru, Sister Institution Network Fund |
| 2010 | IDSA Travel Grant Winner (Mentor) for Dr. Karen Vigil (Fellow in training). Abstract title "Novel influenza A (2009/H1N1) infection in cancer patients during the ongoing pandemic: Early therapy improves outcome", 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, BC, Canada |
| 2009 - 2010 | Finalist, Center for Clinical and Translational Sciences (UTHSCH) Planning Grant for Multi-Institutional Research Program. RO1 Style Proposal: Identification of the Gastro-Intestinal (GI) Microbiota in Patients with Leukemia |
| 2009 | Corresponding Member, Peruvian National Academy of Medicine |
| 2009 | IDSA Travel Grant Winner (mentor), 47th Annual Meeting, Philadelphia, PA for Dr. Karen Vigil (Fellow in Training) "Clinical characteristics and virulence factors of Escherichia coli infections in cancer patients |
| 2009 | IDSA Travel Grant Winner (mentor), 47th Annual Meeting, Philadelphia, PA for Dr. Saud Ahmed (Fellow in Training), "Clinical outcome of multidrug resistant Pseudomonas infections. Does resistance to colistin predict failure in cancer patients |
| 2008 | 1st Place Winner (mentor) Best Clinical Poster Presentation, Second Infections in Cancer Symposium at MD Anderson Cancer Center, Houston, TX for Dr. Karen Vigil (Fellow in Training), "Emergence and control of an outbreak of C. difficile BI/NAP1/027 strain in a comprehensive cancer center." |
| 2008 | ICHS Travel Grant Winner (mentor), 15th Symp on Infections in Immunocompromised Host, Thessaloniki, Greece for Dr. Karen Vigil (Fellow in Training), "Clinical Characteristics and virulence factors of Escherichia coli Pyomyositis: A new entity in our pts with hematologic mali" |
| 2008 | IDSA Travel Grant Winner (mentor), 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC for Dr. Karen Vigil (Fellow in Training) "Escherichia coli (Ec) pyomyositis in hematology cancer patients: Clinical manifestations, cirulence factors and genomic analysis" |
| 2008 | IDSA Travel Grant Winner (mentor), 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC for Dr. Saud Ahmed (Fellow in Training), "Clinical outcome of multidrug-resistance (MDR) gram-negative (GN) infections resistant to colistin in cancer patients |
| 2007 | Best Teacher Award, The University of Texas MD Anderson Cancer Center, Department of Infectious Diseases, Infection Control & Employee Health |
| 2007 | Faculty Development Certificate of Completion, The Heart of Leadership, The University of Texas MD Anderson Cancer Center |
| 2007 | IDSA Travel Grant Winner (mentor), 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, for Dr. Karen Vigil (Fellow in Training), "Molecular epidemiology of clonal outbreak of epidemic multidrug-resistant (MDR) Escherichia coli causing bloodstream infection..." |
| 2007 | Second Place, Clinical Research Project, Cyrus Scholar Award, Division of Internal Medicine 2007 Research Retreat |
| 2007 | Sharon K. Martin Award, First Place, Antimicrobial Stewardship Project in the Intensive Care Unit (ICU), The University of Texas MD Anderson Cancer Center |
| 2006 | Certification of Appreciation, CRC Reviewer, The University of Texas MD Anderson Cancer Center |
| 2005 | IDSA Travel Grant Winner (mentor), 43rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA, for Dr. Halim Aboufaycal (Fellow in Training), "Risk factors and outcome of infection with multidrug-resistant (MDR) Escherichia coli in patients with cancer" |
| 2000 - 2004 | Kass Award Winner (mentor), 42nd Annual Meeting of the Infectious Diseases Society of American, Boston, MA, for Karen Vigil (Internal Medicine Resident) "Enteropathogenic E coli (EPEC) as a cause of diarrhea Peruvian adults in Lima, Peru" |
| 2000 | Finalist Young Investigator Award, The 49th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Houston, TX |
| 1999 | Special Citation Award for Fellows-in-Training, The 37th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA |
| 1998 | Special Citation Award for Fellows-in-Training, The 36th Annual Meeting of the Infectious Diseases Society of America, Denver, CO |
| 1996 | Poster Finalist, 1996 National Associates Research Competition, The 77th Annual Session of the American College of Physicians, San Francisco, CA |
| 1995 | Poster Finalist, 1995 National Associates Research Competition, The 76th Annual Session of the American College of Physicians, Atlanta, GA |
| 1995 | Resident of the Year, Special Award for Research Studies, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI |
| 1994 | Poster Finalist, 1994 National Associates Clinical Vignette Competition, The 75th Annual Session of the American College of Physicians, Miami, FL |
| 1992 | Top Mark Intern, Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia |
| 1992 | Valedictorian, Alberto Hurtado Medical School, Universidad Peruana Cayetano Heredia, Lima, Perú |
| 1984 | First Place,Universidad Peruana Cayetano Heredia Admission Contest, Universidad Peruana Cayetano Heredia |
| 1983 | Valedictorian, La Inmaculada High School, Lima, Perú |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2006. Infections Diarrhea: Review and Focus on Clostridium difficile Infection. Conference. Infections Diarrhea: Review and Focus on Clostridium difficile Infection. Houston, TX, US.
National Presentations
- 2019. Member of Steering Committee, Fourth Infections in Cancer Symposium. Conference. The University of MD Anderson Cancer Center. Houston, TX, US.
- 2018. Invited Speaker, Review of Infection Control video conferences between MDACC and "INEN". Conference. Invited Speaker, Review of Infection Control video conferences between MDACC and "INEN". Houston, TX, US.
- 2018. Invited Speaker, Review of Infectious Endocarditis at MDACC. Conference. MDACC Department of Cardiology. Houston, TX, US.
- 2017. Invited Speaker, Quality Improvement: New Core Knowledge and Tool in Medicine. Conference. Quality Improvement. Houston, TX, US.
- 2016. Invited Speaker, Infectious Complications in Cancer Patients. Conference. A Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2015. Invited Speaker, "What Cancer Patients and Survivors need to know about vaccinations". Conference. Invited Speaker, "What Cancer Patients and Survivors need to know about vaccinations". Houston, TX, US.
- 2014. Moderator and Speaker, Sustained Improvement in the Outcomes of Patients with Multidrug-Resistant Gram Negative Rod Bloodstream Infection. Conference. CS&E, Shared Visions: Improving Systems to Improve Lives. San Antonio, TX, US.
- 2014. Moderator and Invited Speaker, Infectious Diseases in Cancer Patients. Conference. Global Academic Programs 2014 Conference. Seoul.
- 2009. Invited Speaker, Medical Issues in Cancer Survivors Conference. Conference. Invited Speaker, Medical Issues in Cancer Survivors Conference. Houston, TX, US.
International Presentations
- 2024. Invited Speaker, Novel Cancer Therapies and Risk of Infections. Conference. St. Luke's International Hospital. Tokyo, JP.
- 2019. Co-Chairman of Steering Committee, International Symposium of Infections in Cancer. Conference. The University of MD Anderson Cancer Center and St. Luke's International Hospital. Tokyo, JP.
- 2018. Invited Speaker, Meet the Professor. Conference. International Immunocompromised Host Society. Athens, GR.
- 2017. Invited Speaker, Fungal infections in the ICU. Conference. Instituto Nacional de Enfermedades Neoplasicas. Lima, PE.
- 2017. Invited Speaker, Infections in the immunocompromised patients with cancer in the ICU. Conference. Instituto Nacional de Enfermedades Neoplasicas. Lima, PE.
- 2017. Invited Speaker, Rational use of antibiotics in the oncology ICU. Conference. Instituto Nacional de Enfermedades Neoplasicas. Lima, PE.
- 2016. Invited Speaker, Gram-negative bactermia in Cancer Patients through the lens of expert. Conference. Invited Speaker, Gram-negative bactermia in Cancer Patients through the lens of expert. Santiago, CL.
- 2016. Invited Speaker, Novel Chemotherapy and Monoclonal Antibodies Risk of Infections. Conference. Invited Speaker, Novel Chemotherapy and Monoclonal Antibodies Risk of Infections. Santiago, CL.
- 2016. Invited Speaker, Quality Improvement Symposium. Conference. Invited Speaker, Quality Improvement Symposium. Tokyo, JP.
- 2015. Invited Speaker, Conference: Quality Improvement and Infectious Diseases. Conference. Invited Speaker, Conference: Quality Improvement and Infectious Diseases. Lima, PE.
- 2015. Invited Speaker, GI Microbiome and cancer: Impact of the GI microbiome in the oncogenecies and evolution of cancer. Conference. Invited Speaker, GI Microbiome and cancer: Impact of the GI microbiome in the oncogenecies and evolution of cancer. Lima, PE.
- 2014. Invited Speaker, Infectious Complications of Novel Chemotherapy Agents and Monoclonal Antibodies. Conference. The University of Texas MD Anderson Cancer Center and Oncosalud/AUNA. Lima, PE.
- 2013. Invited Speaker,"Research Topics in Infectious Diseases through GAP". Conference. 21st Argentinian and International Conference of Clinical Oncology. Buenos Aires, AR.
- 2013. Invited Speaker, "Fungal Infections in Critically Ill Patients". Conference. Invited Speaker, "Fungal Infections in Critically Ill Patients". Santiago, CL.
- 2013. Invited Speaker, "Review and Update on Neutropenic Fever". Conference. Invited Speaker, "Review and Update on Neutropenic Fever". Santiago, CL.
- 2013. Invited Speaker, "Medical Education and Infectious Diseases Fellowship". Conference. Invited Speaker, "Medical Education and Infectious Diseases Fellowship". Tokyo, JP.
- 2013. Invited Speaker, "Multidrug Resistant Organisms: Management and Antimicrobial Stewardship". Conference. Invited Speaker, "Multidrug Resistant Organisms: Management and Antimicrobial Stewardship". Tokyo, JP.
- 2012. Invited Speaker, Updates in Diagnosis and Treatment of Clostridium difficile Infections. Conference. 14th International Course of Clinical and Radiological Updates. Guadalajara, MX.
- 2012. Invited Speaker, Updates in Management of Patients with Neutropenic Fever. Conference. 14th International Course of Clinical and Radiological Updates. Guadalajara, MX.
- 2011. Invited Speaker, Role of the Gastro-Intestinal Microbiome in Cancer. Conference. The International Symposium Interesting Topics in Oncology in Peru and Around the World. Lima, PE.
- 2011. Invited Speaker, Infections Associated to Novel Chemotherapy Agents and Monoclonal Antibodies. Conference. The International Symposium, Interesting Topics in Oncology in Peru and Around the World. Lima, PE.
- 2011. Invited Speaker, Discussion of Clinical Cases, XXI Peruvian Japanese Clinic International Course. Conference. Invited Speaker, Discussion of Clinical Cases, XXI Peruvian Japanese Clinic International Course. Lima, PE.
- 2011. Invited Speaker, Infections Associated to Novel Chemotherapy Agents and Monoclonal Antibodies. Conference. First Joint International Symposium Between MDACC and "Instituto Nacional de Enfermedades Neoplasicas". Lima, PE.
- 2008. Invited Speaker, The New Problems of an Old Pathogen: Clostridium difficile. Conference. First Symposium of Infections in the Hematological Patient. Madrid, ES.
- 2008. Invited Speaker, Emerging Infections Associated with Novel Chemotherapy Agents and Monoclonal Antibodies. Conference. First Symposium of Infections in the Hematological Patient. Madrid, ES.
- 2007. Invited Speaker, Round Table of Clostridium difficile Associated Diarrhea and other Infectious Diarrhea in Cancer Patients. Conference. Invited Speaker, Round Table of Clostridium difficile Associated Diarrhea and other Infectious Diarrhea in Cancer Patients. Lima, PE.
- 2007. Invited Speaker, Multidisciplinary Antimicrobial Stewardship Program at The University of Texas M. D. Anderson Cancer Center. Conference. Conference in the Peruvian National Academy of Medicine. Lima, PE.
- 2007. Invited Speaker, Update of Clostridium difficile Infections. Conference. International Symposium of Update of Infections in Cancer. Lima, PE.
- 2006. Invited Speaker, Review of Gastrointestinal Parasitic Infections. Conference. Meeting of the Peruvian American Medical Sociekty. Ayacucho, PE.
- 2004. Invited Speaker, Infectious Diarrhea: The tale of a Bacterium. Conference. Meeting of the Peruvian American Medical Society. Cuzco, PE.
- 2002. Invited Speaker, Yellow Fever and Dengue. Conference. Update Conference in Medicine. Le Merced, PE.
- 2001. Invited Speaker, Tropical and Infectious Diseases in the New Millenium. Conference. XL Anniversary of Universidad Peruana Cayetano Heredia. Lima, PE.
- 2001. Invited Speaker, New Laboratory Diagnostics Methods in Uveitis. Conference. VIII Regional Congress of Ophthalmology, Peruvian Society of Ophthalmology. unknown, PE.
- 2001. Invitied Speaker, Travelers’ Diarrhea: Basic Concepts and Advances in Therapy. Conference. Congress of the Pan-American Medical Society. Trujillo, PE.
- 2001. Invited Speaker, Microbiology of Acute Sinusitis, Acute Rhino-Sinusitis Course. Conference. Peruvian Society of Ear, Nose & Throat and Facial Surgery. Lima, PE.
Formal Peers
- 2006. Invited Speaker, Review of Gastrointestinal Parasitic Infections. Invited. Detroit, MI, US.
- 2006. Invited Speaker, Update and Review of Clostifium difficile Infections. Invited. Detroit, MI, US.
- 2006. Invited Speaker, Eye Infections: Show and Tell. Invited. Detroit, MI, US.
- 2005. Invited Speaker, Update in Neutropenic Fever. Invited. Guadalajara, MX.
- 2004. Invited Speaker, Update in Meningo-encephalitis. Invited. Guadalajara, MX.
- 2004. Invited Speaker, Traveler's Diarrhea. Invited. Detroit, MI, US.
- 2001. Invited Speaker, Human Genome and Bioterrorism. Invited. Lima, PE.
- Visiting Professor. Visiting. Lima, PE.
Grant & Contract Support
| Date: | 2017 - 2019 |
| Title: | The Cervical Cancer Microbiome: Driver of Malignant Progression and Treatment resistance? |
| Funding Source: | MD Anderson Cancer Center |
| Role: | Collaborator |
| Date: | 2009 - Present |
| Title: | CME/CE, CPE and CNE Activities |
| Funding Source: | Merck & Co., Inc |
| Role: | PI |
| Date: | 2006 - Present |
| Title: | CME/CE Support Program |
| Funding Source: | Merck & Co., Inc |
| Role: | PI |
| Date: | 2006 |
| Title: | Microbial contamination of fruits served at Mexican restaurants - Fecal coliforms and enteric pathogens. Guadalajara |
| Funding Source: | In collaboration with Dr. Herbert Dupont |
| Role: | Co-I |
| Date: | 2006 |
| Title: | Microbial contamination of deserts served at Mexican restaurants - Fecal coliforms and enteric pathogens. Guadalajara |
| Funding Source: | In collaboration with Dr. Herbert Dupont |
| Role: | Co-I |
| Date: | 2005 - 2006 |
| Title: | Surveillance of antimicrobial resistance in Staphylococcus aureus and enterococci from Colombian, Peruvian and Ecuadorian hospitals: An update 2005-2006 |
| Funding Source: | Pfizer Global Pharmaceuticals |
| Role: | Co-I |
| ID: | unknown |
| Date: | 2005 |
| Title: | Epidemiology, etiology and pathogenesis of post-infectious irritable bowel syndrome. Guadalajara |
| Funding Source: | In collaboration with Dr. Herbert DuPont |
| Role: | Co-I |
| Date: | 2005 |
| Title: | A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Rifaximin for the prevention of travelers’ diarrhea. Guadalajara |
| Funding Source: | In collaboration with Dr. Herbert DuPont |
| Role: | Co-I |
| Date: | 2005 |
| Title: | Microbial contamination of vegetables served at Mexican restaurants – Fecal coliforms and enteric pathogens. Guadalajara |
| Funding Source: | In collaboration with Dr. Herbert DuPont |
| Role: | Co-I |
| Date: | 2003 - 2006 |
| Title: | Study of the relation between mucositis and gastro-intestinal infections in cancer patient |
| Funding Source: | Unknown |
| Role: | Co-I |
| Date: | 2003 - 2006 |
| Title: | Study of the efficacy and safety of rifaximin for the treatment and prophylaxis of different infections in cancer patients: Escherichia coli bacteremia, C. difficile associated colitis, gastro-intestinal tract infections, prophylaxis of neutropenic fever, others |
| Funding Source: | Unknown |
| Role: | Co-I |
| Date: | 2003 - 2006 |
| Title: | Study of new antiviral therapies for RSV and CMV |
| Funding Source: | Unknown |
| Role: | Co-I |
| Date: | 2003 - 2006 |
| Title: | Study of new antimicrobial agents for resistant bacteria |
| Funding Source: | Unknown |
| Role: | Co-I |
| Date: | 2003 - 2006 |
| Title: | Study of new antifungals in immunocompromised patients with cancer |
| Funding Source: | Unknown |
| Role: | Co-I |
| Date: | 2003 - Present |
| Title: | Study of Clostridium difficile infection in cancer patients: Microbiology, molecular biology, epidemiology, physiopathology, risk factors, diagnosis, clinical manifestations, treatment and prevention |
| Funding Source: | Center for Infectious Diseases |
| Role: | PI |
| Date: | 1996 - 2003 |
| Title: | Study of a new delivery system for oral vaccination, Allergenics, Inc., Cincinnati, Ohio |
| Funding Source: | Allergenics, Inc |
| Role: | Collaborator |
| Date: | 1996 - 2006 |
| Title: | Study of in-vitro antimicrobial susceptibility of bacterial enteropathogens causing travelers’ diarrhea around the world |
| Funding Source: | Center for Infectious Diseases |
| Role: | Collaborator |
| Date: | 1996 - 2006 |
| Title: | Study of bacterial contamination of food in Guadalajara-Mexico and Houston-Texas |
| Funding Source: | Center for Infectious Diseases |
| Role: | Collaborator |
| Date: | 1996 - 2006 |
| Title: | Study of enterotoxigenic Escherichia coli infection: Microbiology, molecular biology, epidemiology, diagnosis, clinical manifestation, treatment and prevention |
| Funding Source: | Center for Infectious Diseases |
| Role: | Collaborator |
| Date: | 1996 - 2006 |
| Title: | Study of new medicines for the treatment of travelers’ diarrhea: Rifaximin, levofloxacin, azithromycin, provir, lactoferrin |
| Funding Source: | Center for Infectious Diseases |
| Role: | Collaborator |
| Date: | 1996 - 2006 |
| Title: | Organization, participation and supervision of basic research and clinical trials in different field study centers (Lima-Peru, Guadalajara-Mexico and Montego Bay-Jamaica) |
| Funding Source: | In collaboration with Dr. Herbert DuPont |
| Role: | Collaborator |
| Date: | 1996 - Present |
| Title: | Study of enteroaggregative Escherichia coli infection: Microbiology, molecular biology, epidemiology, fisiopathology, diagnosis, clinical manifestation, treatment and prevention |
| Funding Source: | Center for Infectious Diseases |
| Role: | Research Member |
| Date: | 1994 - 1996 |
| Title: | Study of new diagnostic techniques for detection of HIV p32 |
| Funding Source: | Henry Ford Hospital |
| Role: | Research Assistant |
| Date: | 1992 - 1998 |
| Title: | Study of in-vitro susceptibility of Vibrio cholerae, Salmonella and Brucella |
| Funding Source: | Peruvian National Cancer Institute |
| Role: | Research Advisor |
| Date: | 1988 - 1993 |
| Title: | Study of in-vitro susceptibility and epidemiological surveillance of Vibrio cholerae, Salmonella spp., Brucella spp., Shigella spp., Neisseria gonorrhoeae and Streptococcus pneumoniae |
| Funding Source: | Universidad Peruana Cayetano Heredia |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Allos, H, Hicklen, RS, Matsuo, T, Adachi, JA, Wurster, ST, Kontoyiannis, DP. The Heterogenous Presentation of Hepatic Mucormycosis in Adults. Journal of Fungi 11(6), 2025. e-Pub 2025. PMID: 40558921.
- Hazim A, Hicklen RS, Takahiro M, Adachi JA, Sebastian W, Kontoyiannis DP. The Heterogenous Presentation of Hepatic Mucormycosis in Adults: A Case Report and Review of the Literature 11(6), 2025. e-Pub 2025.
- Tverdek, FP, Aitken, SL, Mulanovich, VE, Adachi, JA, Wu, C, Cantu, S, McDaneld, PM, Chemaly, RF. Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infectious Diseases 11(5), 2024. e-Pub 2024. PMID: 38798895.
- Marvin-Peek, J, Sasaki, K, Kontoyiannis, DP, Adachi, JA, Ohanian, M, Takahashi, K, Issa, GC, Kornblau, SM, Abbas, HA. Nontuberculosis mycobacteria (NTM) infections in patients with leukemia. Frontiers in Medicine 11, 2024. e-Pub 2024. PMID: 39149601.
- Holloway S, McConn K, Borchardt R, Mulanovich VE, Adachi JA. Mitigating Burnout: Transition to a Condensed Workweek for Advanced Practice Providers in Infectious Diseases. J Adv Pract Oncol 14(7):639-643, 2023. e-Pub 2023. PMID: 38196670.
- Raad, II, Hachem, RY, Masayuki, N, Datoguia, TS, Dagher, H, Jiang, Y, Subbiah, V, Siddiqui, B, Bayle, A, Somer, RA, Fernández-Cruz, A, Gorak, E, Bhinder, A, Mori, N, Hamerschlak, N, Shelanski, S, Dragivich, T, Kiat, YV, Fakhreddine, S, Hanna, PA, Chemaly, RF, Mulanovich, VE, Adachi, JA, Borjan, J, Khawaja, F, Granwehr, BP, John, TM, Yepez Guevara, E, Torres, HA, Ammakkanavar, NR, Yibirin, M, Reyes-Gibby, CC, Pande, M, Ali, N, Rojo, RD, Ali, S, Deeba, R, Chaftari, P, Matsuo, T, Ishikawa, K, Hasegawa, R, Aguado-Noya, R, García, ÁG, Puchol, CT, Lee, DG, Slavin, MA, Teh, B, Arias, CA, Kontoyiannis, DP, Chaftari, AP. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer. eLife 12, 2023. e-Pub 2023. PMID: 36715684.
- Francisco, D, Zhang, L, Jiang, Y, Olvera, AV, Adachi, JA, Yepez Guevara, E, Aitken, SL, Garey, K, Peterson, CB, Do, K, Dillon, R, Obi, EN, Jenq, RR, Okhuysen, PC. Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer. Infectious Diseases and Therapy 12(1):209-225, 2023. e-Pub 2023. PMID: 36443547.
- Robins, A, Dishner, E, McDaneld, PM, Rowan, M, Bartek, J, Jiang, Y, Adachi, JA, Dailey Garnes, NM. Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors. Supportive Care in Cancer 30(2):1643-1654, 2022. e-Pub 2022. PMID: 34550460.
- Mori, N, Szvalb, AD, Adachi, JA, Tarrand, JJ, Mulanovich, VE. Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer. BMC Infectious Diseases 21(1), 2021. e-Pub 2021. PMID: 34587893.
- Malek, A, Adachi, JA, Mulanovich, VE, Sassine, J, Raad, II, Mcconn, KK, Seiler, GT, Dhal, U, Khawaja, F, Chemaly, RF. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients. Transplant Infectious Disease 23(4), 2021. e-Pub 2021. PMID: 33755273.
- Yepez Guevara, E, Aitken, SL, Olvera, AV, Carlin, LG, Fernandes, KE, Bhatti, MM, Garey, K, Adachi, JA, Okhuysen, PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients. Clinical Infectious Diseases 72(10):E460-E465, 2021. e-Pub 2021. PMID: 32803229.
- Greenbaum, U, Klein, K, Martinez, F, Song, J, Thall, PF, Ramdial, JL, Knape, C, Aung, FM, Scroggins, J, Knopfelmacher Couchonal, AM, Mulanovich, VE, Borjan, J, Adachi, JA, Muthu, M, Leung, CK, Correa Medina, M, Champlin, RE, Olson, AL, Alousi, AM, Rezvani, K, Shpall, E. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Frontiers in immunology 12, 2021. e-Pub 2021. PMID: 33995420.
- John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95(9):2038-2040, 2020. e-Pub 2020. PMID: 32861345.
- Abu-Sbeih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi JA, Hachem RY, Altan M, Jenq RR, Wang Y. Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum 63(3):381-388, 2020. e-Pub 2020. PMID: 31842164.
- Malek AE, Gutierrez C, Mulanovich VE, Botdorf J, Chemaly RF, Shah S, McCall BM, Melancon JT, McConn KK, Borjan J, Raad II, Burger JA, Garcia-Manero G, Adachi JA. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. Mediterr J Hematol Infect Dis 12(1):e2020044, 2020. e-Pub 2020. PMID: 32670522.
- Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Vong Kiat YE, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García-García Á, Puchol CT, Lee D, Slavin M, Teh B, Arias CA, Effort Team DDFCOD, Kontoyiannis DP, Malek AE, Chaftari A. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. PMID: 36097568.
Abstracts
- Mulanovich P, Chemaly R, Granwehr B, McConn K, Patel N, Raad I, Adachi J. Covid-19 In a Comprehensive Cancer Center: 2020-2022. ID Week 2022, 2022. e-Pub 2022.
- Pereira M, Cervera C, Kotton C, Sasadeusz J, Wu J, Fournier M. Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results. ID Week 2021, Virtual Event 8(1):S14-S15, 2021. e-Pub 2021.
- Hachem R, Chaftari A, Nigo M, Hamerschlak N, Dagher H, Jiang Y, Siddiqui B, Bayle A, Somer R, Fernandez Cruz A, Gorak E, Bhinder A, Mori N, Datoguia T, Shelanski S, Dragvich T, Vong Kiat Y, Fakhreddine S, Abi Hanna P, Chemaly R, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez Guevara E, Torres H, Slavin M, Teh B, Subbiah V, Kontoyiannis D, Malek A, Raad I. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome. ID Week 2021, Virtual Event 8(1):S15, 2021. e-Pub 2021.
- Mori N, Szvalb AD, Adachi JA, Tarrand JJ, Mulanovich VE. Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer. BMC Infect Dis 1:1021, 2021. e-Pub 2021.
- Hachem R, Datoguia T, Siddiqui B, Fernandez Cruz A, Mori N, Fakhreddine S, Lee D, Gorak E, Somer R, Bhinder A, Shelanski S, Draivich T, Bayle A, Chemaly R, Mulonovich V, Adachi, J, Malek A, Slavin M, Jiang Y, Chaftari A, Raad I. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study. ID Week 2020, Virtual Event 7(1):S256, 2020. e-Pub 2020.
- Yepez Guevara E, Aitken S, Olvera A, Carlin L, Fernandes K, Bhatti M, Garey K, Adachi JA, Okhuysen P. Clinical outcomes, bacterial loads, and markers of intestinal inflammation in immunocompromised and cancer with diarrhea and Clostridioides difficile identified by nucleic acid amplication tests (NAAT) and toxin A/B by enzyme immuoassay (EIA). The 29th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Holland, 2019, 2019. e-Pub 2019.
- Foolad F, Berlin S, White C, Dishner E, Jiang Y, Adachi JA, Taremi M. The Impact of penicillin skin testing (PST) on aztreonam stewardship and cost savings in immunocompromised cancer patients. The 29th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Holland, 2019, 2019. e-Pub 2019.
- Sakurai A, Adachi JA. Impact of Fiberoptic Bronchoscopy on Microbiologicol Diagnostic Rate and Clinical Outcomes of Pneumonia in Acute leukemia patients. 57th Annual Meeting of the IDSA, Washington DC, 2019. e-Pub 2019.
- Sakurai A, Bala-Hampton J, Mulanovich V, William W, Cortes JE, Adachi JA. Effective & Early Diagnosis of Pneumonia in Patients with Acute Leukemia in a Comprehensive Cancer Center: How can we improve the microgiological diagnosis?. ID Week 2018, San Francisco, CA 2018, 2018. e-Pub 2018.
- Taremi M, Artau A, Foolad F, Berlin S, White C, Mulanovich V, Raad I, Adachi JA. Safety and Efficacy of Penicillin Allergy Skin Testing in Immunocompromised Hosts at a Comprehensive Cancer Center. ID Week 2018, San Francisco, CA 2018, 2018. e-Pub 2018.
- Taremi M, Artau A, Foolad F, Berlin S, White C, Haddad E, Bala-Hampton J, Mulanovich V, Raad I, Adachi J. Safety and efficacy of penicillin allergy skin testing in immunocompromised hosts at a comprehensive cancer center. 28th European Congress of Clinical Microbiology and Infectious Diseases, 2018, 2018. e-Pub 2018.
- Sakurai A, Adachi JA. Effective & Early Diagnosis of Pneumonia in Patients with Acute Leukemia in a Comprehensive Cancer Center: How can we improve the microbiological diagnosis?. 56th Annual Meeting of the IDSA, San Francisco, CA 2018. e-Pub 2018.
- Taremi M, Artau A, Foolad F, Berlin S, White C, Mulanovich V, Raad I, Adachi JA. Safety and Efficacy of Penicillin Allergy Skin Testing in Immunocompromised Hosts at a Comprehensive Cancer Center. International Immunocompromised Host Society, Athens, Greece, 2018, 2018. e-Pub 2018.
- Dishner E, Adachi JA. Infectious Diseases (ID) Complications in Immunocompromised (IC) Patients with Cancer Post-Hurricane Harvey at a Comprehensive Cancer Center in 2017. ID Week 2018, San Francisco, CA 2018, 2018. e-Pub 2018.
- Dishner E, MdDaneld P, Rowan M, Adachi J, Dailey-Garnes J. Implementation of an Effective Outpatient Parenteral Antimicrobial Therapy Service in a Comprehensive Cancer Center. The Institute for Healthcare Improvement on Quality Improvement in Health Care National Forum 2018, Orlando, Florida, 12/2018, 2018. e-Pub 2018.
- Vigil KJ, Ajami NJ, Lewis D, Couturier J, Adachi JA, Petrosino JF. Changes in the Gut and Blood Microbiome After Starting Antiretroviral Therapy in HIV-1 Infected Patients. 9th IAS Conference on HIV Science, Paris, France 2017, 2017. e-Pub 2017.
- Dishner E, Adachi JA. Infectious Diseases (ID) Complications in Immunocompromised (IC) Patients with Cancer Post-Hurricane Harvey at a Comprehensive Cancer Center in 2017. 56th Annual Meeting of the IDSA, San Francisco, CA 2018. e-Pub 2017.
- Mullane K, Adachi J, Dubberke E, Alexander B, Broyde N, Sears P. Outcomes of DEFLECT-1: A Multicenter, Blinded, Randomized Clinical Trial of Fidaxomicin Versus Placebo for Prophylaxis of Clostridium difficile-Associated Diarrhea in Patients Undergoing Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant (BMT) 2016 Tandem CIBMTR/ASBMT Meeting, Honolulu, Hawaii, 2016. e-Pub 2016.
- Kitkunguam D, Vejpongsa P, Yusuf W, Adachi J, Banchs J. Endocarditis in Cancer Patients with and without Thrombocytopenia:Prevalance and Complication Rates. American College of Cariology 64th Annual Scientific Session 2015, San Diego, CA 2015, 2015. e-Pub 2015.
- Mori N, El Zakhem A, Williams P, Jiang Y, Tarrand J, Adachi J. Multidrug-Resistant Gram Negative Rods Bloodstream Infections in Cancer Patients. ICAAC/ICC 2015, 2015. e-Pub 2015.
- Munita J, Rios R, Reyes J, Tran T, Panesso D, Smith D, Rincon S, Carvajal L, Garavito J, Castellanos M, Adachi J, Arias C, Dias L. Substitutions in LiaFSR and Enzymes involved in Glycerophospholipid Metabolism correlate with high-level DAP-Resistance in vivo in E. faecium. ID Week 2015, San Diego, CA, 2015, 2015. e-Pub 2015.
- Mullane K, Adachi J, Dubberke E, Alexander B, Broyde N, Sears P. Outcomes of DEFLECT-1: A multicenter, Blinded, Randomized Clinical Trial of Fidaxomicin (FDX) vs. Placebo (PLC) for Prophylaxis of Clostridium difficile Associated Diarrhea (CDAD) in Subjects undergoing Hemtopoietic Stem Cell Transplantation (HSCT). IDWeek 2015 Advancing Science, Improving Care, San Diego, CA, 2015. e-Pub 2015.
- Shelburne S, Reyes K, Lewis J, Rincon S, Panesso D, Adachi J, Sifri C, Zervos M, Munita J, Hasbun R, Arias C. Influence of MIC in Clinical Outcomes of Enterococcus faecium Bacteremia Treated with Daptomycin:Is it Time to Change the Breakpoint?. ID Week 2015, San Diego, CA, 2015, 2015. e-Pub 2015.
- Mori N, Szvalb A, Adachi J, Jiang Y, Mulanovich V. Non-typhoidal Salmonella Infections in Cancer Patients. ID Week 2014, Philadelphia, PA, 2014. e-Pub 2014.
- Williams P, Adachi J. Sustained Improvement in the Outcomes of Patients with Multidrug-Resistant Gram Negative Rod Bloodstream Infection. CS&E, Shared Visision:Improving Systems to Improve Lives, San Antonio, TX, 2014. e-Pub 2014.
- Mori N, El Zakhem A, Williams, P, Adachi J. Improving the outcomes of cancer patients with multidrug-resistant gram negative rods bloodsteam infections. Global Academic Programs 2014 Conference, Seoul, Korea, 2014. e-Pub 2014.
- Mori N, Williams P, Vigil K, Tarrand J, Jiang Z, DuPont H, Adachi J. Infectous Myositis Secondary to Multidrug-Resistant Gram Negative Rods in Cancer Patients. IDWeek 2014, Philadelphia, PA, 2014. e-Pub 2014.
- Mori N, El Zakhem A, Williams P, Adachi J. Improving the outcomes of cancer patients with multidrug-reistant gram negative rods bloodstream infections. The University of Texas MD Anderson Cancer Center, CSE Conference, 2013. e-Pub 2013.
- Crowther DM, Tverdek FP, Ghantoji S, Adachi JA, Chemaly RF. The use of fidaxomicin for the treatment of clostridium difficile infection (CDI) in patients with cancer. DoIM Research Retreat, Houston, TX, 2013. e-Pub 2013.
- Mori N, El Zakhem A, Williams, P, Adachi J. Improving the outcomes of cancer patients with multidrug-resistant gram negative rods bloodstream infections. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
- Mori N, El Zakhem A, Williams P, Adachi J. Improving the outcomes of cancer patients with multidrug-reistant gram negative rods bloodstream infections. DoIM Research Retreat, Houston, TX, 2013. e-Pub 2013.
- Crowther DM, Tverdek FP, Ghantoji S, Adachi JA, Chemaly RF. The use of fidaxomicin for the treatment of clostridium difficile infection (CDI) in patients with cancer. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
- Mori N, DuPont H, Jiang ZD, El Zakhem A, Williams P, Van Tassel A, Cantu S, Good C, Dvorak T, Reitzel R, Tarrand J, Raad I, Chemaly R, Adachi JA. Increasing Rates of Multi-Drug Resistant Organism Bloodstream Infections in a Comprehensive Cancer Center: Rifaximin as a Novel Alternative for Antimicrobial Prophylaxis. 50th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 2012. e-Pub 2012.
- Shelburne S, White C, El Zakhem A, Mori N, Adachi J. Improving the outcomes of patients with Staphylococcus aureus bacteremia. CS&E, Building the Bridge:Maintaining Quality in the Face of Change, San Antonio, TX, 2012. e-Pub 2012.
- Williams P, El Zakhem A, Mori N, Adachi J. Improving the Outcomes of Patients with Multidrug-Resistant Gram Negative Rods Bloodstream Infections. CS&E, Building the Bridge:Maintaining Quality in the Face of Change, San Antonio, TX, 2012. e-Pub 2012.
- Torres HA, Roach LR, Smith KM, Mahle R, Raad II, Adachi J. Increase rate of patients with Hepatitis C infection treated with antiviral therapy at MD Anderson Cancer Center. 2011 University of Texas System Clinical Safety and Effectiveness Conference, San Antonio, Texas, 2011. e-Pub 2011.
- Granwehr B, Adachi JA. Optimization of the inpatient consultation process at MD Anderson Cancer Center. 2011 University of Texas System Clinical Safety and Effectiveness Conference, San Antonio, Texas, 2011. e-Pub 2011.
- Zuniga J, Rolston KV, Adachi J. Neutropenic enterocolitis complicating taxane-based chemoherapy in cancer patients. 49th Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2011. e-Pub 2011.
- Vigil KJ, Adachi JA, Jiang Y, Papat UR, Mahani MG, Granwehr B, Malik I, Gaeta S, Champlin RE, Raad I, Chemaly R. Novel influenza A (2009/H1N1) infection in cancer patients during the ongoing pandemic: Early therapy improves outcome. 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, Canada, 2010. e-Pub 2010.
- Shah J, Mahajan SN, Hachem R, Adachi JA, Mulanovich VE, Rolston KVI, Raad I, Chemaly R. Outcome of MRSA bacteremia (BSI) in cancer patients treated with vancomycin. 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, Canada, 2010. e-Pub 2010.
- Vigil KJ, Adachi JA, Jiang Y, Papat U, Mahani MG, Granwehr BP, Gaeta S, Malik I, Champlin R, Raad II, Chemaly RF. Novel influenza A (2009/H1N1) infection in patients with hematological malignancies during the 2009 panemic outbreak: Early antiviral treatment improves survival. 2010 Annual Meeting of the American Society of Hamtology, Orlando, Florida, 2010. e-Pub 2010.
- Vigil, KJ, Cuellar LE, Miranda L, Vicente W, Jiang ZD, Adachi JA, DuPont H. Clostridium difficile infection in cancer patients in a comprehensive cancer center in Lima, Peru. 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, Canada, 2010. e-Pub 2010.
- Chemaly RF, Sikka MK, Rathod DB, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Raad I, Trenholme G. Clinical outcome of patients with Serratia marcescens bacteremia (SMB) due to contaminated pre-filled heparin and saline flushes in 3 states. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Vigil KJ, Adachi JA, Ajami N, Johnston B, Z-D J, Tarrand J, Raad II, Johnston JR, DuPont HL. Clinical characteristics and virulence factors of Escherichia coli infections in cancer patients. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Rathod DB, Vigil K, Adachi J, Shah J, Raad I, Chemaly RF. Clostridium difficile infection in cancer patients: A case-control study. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Shah JN, Hachem RY, Rathod DB, Adachi JA, Mulanovich VE, Raad II, Chemaly RF. Outcome of MRSA bactremia (BSI) in cancer patients treated with Vancomycin. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Vigil KJ, Adachi J, Ajami N, Tarrand J, Jiang Z, DuPont HL. Extraintestinal pathogenic Escherichia coli (ExPEC) pneumonia in cancer patients. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Raad II, Chemaly RF. Influenza virus infections in pediatric cancer patients-emphasis on preemptive therapy. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Mulanovich VE, Chemaly RF, Borchardt RA, Smith KM, Perego CA, Mihu CN, Raad II, Rolston KVI, Adachi JA. Antimicrobial stewardship project in the intensive care unit (ICU) of a comprehensive cancer center: Impact on quality of care and patient safety. 19th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA), San Diego, CA, March 19-22, 2009. e-Pub 2009.
- Ahmed, SI, Lasala PR, Vigil KJ, Ozurk T, Hachem R, Adachi JA. Clinical outcome of multidrug resistant (MDR) Pseudomonas infections. Does resistance to colistin predict failure in cancer patients?. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009. e-Pub 2009.
- Chemaly RF, Graviss L, Tarrand J, Han XY, LaSala PR, Adachi A, Morice R, Raad I. Pseudo-outbreak of Mycobacterium mucogenicum infection assoicated with contaiminated water supply. The Society for Healthcare Epidemiology of America, Orlando, FL, 2008. e-Pub 2008.
- Borchardt R, Taylor M, Hafemeister L, Kelsnick J, Salazar I, Smith K, Perego C, Adachi J, Mulanovich V. Urgent consults in the infectious diseases clinic. Clinical safety and effectiveness. Alumni Meeting. The University of Texas M. D. Anderson Cancer Center, 2008. e-Pub 2008.
- Ahmed SI, Hachem RY, Adachi JA. Clinical outcome of multidrug-resistance (MDR) gram-negative (GN) infections resistant to colistin in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Johnson J, Cooperstock M, Johnston B, Menard M, Thurn J, Clabots C, Assimacopoulos A, M-H N, Russo T, DuPont H, Vigil K, Adachi J, Rice J. Fluoroquinolone-resistant (FQ-R) E. coli (Ec) infections in the United States (US): Predominance of Ec sequence type ST131 (025:H4). 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Vigil KJ, Johnson JR, Johnston B, Kontoyiannis DP, Mulanovich VE, Safdar A, Tarrand JJ, Chemaly RF, Raad II, Adachi JA. Clinical characteristics and virulence factors of Escherichia coli Pyomyositis: A new entity in our patients with hematologic malignancies. DoIM Research Retreat, Houston, TX, 2008. e-Pub 2008.
- Adachi J, Vigil K, Dvorak T, Hachem R, Chemaly R, Raad I. Molecular epidemiology of a clonal outbreak of epidemic multidrug-resistant (MDR) Escherichia coli causing bloodstream infection in cancer patients, Abstract #08-060. Multinational Association of Supportive Care in Cancer 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):658, 2008. e-Pub 2008.
- Mulanovich V, Borchardt R, Chemaly RF, Perego C, Adachi J. Antimicrobial Stewardship Project in the Intensive Care Unit. Phase II Clinical Safety and Effectiveness Alumni Meeting, The University of Texas M. D. Anderson Cancer Center, 2008. e-Pub 2008.
- Panesso D, Reyes JC, Zurita J, Rincon S, Carrillo C, Guzman M, Diaz L, Contreras G, Melo Z, Chowdhury SA, Adachi JA, Murray BE, Arias CA. Molecular characterization of vancomycin-resistant enterococci (VRE) from latin-american hospitals: A prospective study, 2006-2007. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Hanmod S, Khoury A, Adachi J, Hachem R, Safdar A, Chemaly R. Cytomegalovirus infection in patients with solid tumors, Abstract #08-065. Multinational Association of Supportive Care in Cancer 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):661, 2008. e-Pub 2008.
- Vigil KJ, Johnson JR, Johnston B, Kontoyianis DP, Mulanovich VE, Safdar A, Tarrand JJ, Chemaly RF, Raad II, DuPont HL, Adachi JA. Clinical characteristics and virulence factors of Escherichia coli Pyomyositis: A new entity in our patients with hematologic malignancies. 15th Symposium on Infections in the Immunocompromised Host, Thessaloniki, Greece, 2008. e-Pub 2008.
- Vigil KJ, Johnson JR, Johnston B, Kontoyiannis DP, Mulanovich VE, Safdar A, Tarrand JJ, Chemaly RF, Raad II, DuPont HI, Adachi JA. Clinical characteristics and virulence factors of Escherichia coli Pyomyositis: A new entity in our patients with hematologic malignancies. 2nd Infections in Cancer Symposium, Houston, TX, 2008. e-Pub 2008.
- Reyes J, Rincon S, Diaz L, Panesso D, Contreras GA, Zurita J, Carrillo C, Guzman M, Adachi JA, Chowdhury A, Murray BE, Aria CA. Molecular epidemiology of MRSA in latin-american hospitals: A prospective study, 2006-2007. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Georgescu G, Isola IM, Youssef S, Adachi J, Rolston K. Disseminated salmonellosis in a patient treated with temozolomide, Abstract #08-064. Multinational Association of Supportive Care in Cancer 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):660, 2008. e-Pub 2008.
- Ramos E, Hachem R, Adachi J, Rolston K, Raad I, Chemaly R. Methicillin resistant staphylococcus aureus pneumonia in cancer patients: High failure rate with vancomycin, Abstract #08-069. Multinational Association of Supportive Care in Cancer 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):663, 2008. e-Pub 2008.
- Chaftari AM, Hachem R, Mulanovich V, Chemaly R, Adachi J, Kassar R, Ramos E, Jiang J, Raad I. Efficacy and safety of daptomycin in the treatment of gram positive catheter-related bloodstream infections (CRBSI) in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Chemaly RF, Hanmod S, Mulanovich V, Adachi J, Rolston K, Raad I. Efficacy and safety of daptomycin in the treatment of gram positive catheter-related bloodstream infections (CRBSI) in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Adachi J, Perego C, Vigil K, Mulanovich V, Chemaly R, Rolston K. Antibiotic stewardship initiative in the intensive care unit (ICU): Evidence from a quality improvement project supporting the development of a multidisciplinary antimicrobial stewardship team, Abstract #08-059. Multinational Association of Supportive Care in Cancer (MAST) 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):658, 2008. e-Pub 2008.
- Chemaly RF, Tarrand J, Adachi J, Nguyen K, Awosika-Olumo D, Short K, Pascoe N, Graviss L, Mulanovich V, Granwehr B, Rolston K, Raad I. Investigation of an outbreak of Seratia marcescens bacteremia in cancer patients leading to a national recall of a second unsuspected contaminated source: Time for antimicrobial lock therapy?. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Ahmed A, Campo M, Kontoyiannis DP, Adachi JA. Fulminant zygomycosis in a neutropenic leukemia patient on chronic voriconazole phophylaxis. 2nd Infections in Cancer Symposium, Houston, TX, 2008. e-Pub 2008.
- Rathod D, Vigil K, Adachi J, Burton L, Perego C, Jiang Z, DuPont H, Raad I, Chemaly RF. Characteristics and outcome of Clostridium difficile infection (cdi) in cancer pateints (pts). 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington DC, 2008. e-Pub 2008.
- Vigil KJ, Ahmed A, Mulanovich VE, Safdar A, Raad II, Johnson JR, Adachi JA. A singular case of Escherichia coli Pyomycositis in a neuropenic leukemia patient. 2nd Infections in Cancer Symposium, Houston, TX, 2008. e-Pub 2008.
- Vigil KJ, Johnson J, Johnston B, Kontoyiannis D, Mulanovich V, Tarrand J, Chemaly R, Reitzel R, Raad I, DuPont HL, Adachi J. Escherichia coli (Ec) pyomyositis in hematology cancer patients: Clinical manifestations, virulence factors and genomic analysis. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Vigil KJ, Adachi JA, Jiang ZD, Rhatod DB, Burton L, Tarrand J, DuPont HL, Raad II, Chemaly RF. Emergence and control of an outbreak of Clostridium difficile BI/NAP1/027 strain in a comprehensive cancer center. The Society for Healthcare Epidemiology of America, Orlando, FL, 2008. e-Pub 2008.
- Ramos ER, Hachem R, Mulanovich V, Adachi J, Kontoyiannis D, Rolston K, Safdar A, Raad II, Chemaly RF. Characteristics and outcome of methicillin resistant Staphylococcus aureus pneumonia (MRSA-p) in cancer patients (pts) after initial therapy with vancomycin. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Chemaly RF, Hanmod S, Mulanovich V, Adachi J, Rolston K, Raad I, Hachem R. Tigecycline usage in cancer patients with serious infections: A report on 110 cases from a single institution. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
- Adachi JA, Perego C, Hogan H, Vigil K, Youssef S, Pravinkumar E, Rolston K. Antibiotic stewardship initiative in the intensive care unit (ICU). 2nd Clinical Safety and Effectiveness Alumni Meeting, The University of Texas M. D. Anderson Cancer Center, 2007. e-Pub 2007.
- Adachi JA, Perego C, Hogan H, Vigil K, Youssef S, Pravinkumar E, Chemaly R, Rolston K. Antibiotic stewardship initiative in the intensive care unit (ICU): Evidence from a quality improvement project supporting the development of a multidisciplinary antimicrobial stewardship team (MAST). Division of Internal Medicine Research Retreat, 2007. e-Pub 2007.
- Chemaly R, Hachem R, Hanmod S, Adachi JA, Hogan H, Mulanovich V, Kontoyiannis D, Safdar A, Raad, I, Rolston K. Tigecycline usage in cancer patients with refractory pneumonia: A report on 38 cases. A single-institution study. 17th European Congress of Clinical Microbiology and Infectious Diseases & 25th International Congress of Chemotherapy, Munich, Germany, 2007. e-Pub 2007.
- DuPont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, Huang BD, DuPont MW, Adachi JA, de la Cabada FJ, Taylor DN, Sandoval FM. Treatment of travelers' diarrhea: Rifaximin, rifaximin plus loperamide or loperamide alone. North European Conference on Travel medicine, Centre, Edinburgh, Scotland, 2007. e-Pub 2007.
- Hanmod S, Baradhi A, Kontoyiannis D, Adachi J, Mulanovich V, Hachem R, Safdar A, Raad I, Chemaly RF. Cytomegalovirus infection in patients with solid tumors. 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, Abstract #761, 2007. e-Pub 2007.
- Vigil KJ, Z-D J, Pulido C, Adachi JA, Jiang Y, DuPont MW, Ericsson CD, DuPont HL. Enterobacteriacae contamination of desserts from Guadalajara, Mexico. 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, Abstract #1605, 2007. e-Pub 2007.
- Adachi JA, Vigil K, Aboufaycal H, Dvorak T, Hachem R, Tarrand J, Perego C, Williams P, Chemaly R, Rolston K, Raad I. Molecular epidemiology of a clonal outbreak of epidemic multidrug-resistant (MDR) Escherichia coli causing bloodstream infection in cancer patients. 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, Abstract #1561, 2007. e-Pub 2007.
- Ramos E, Hachem RY, Mulanovich V, Adachi JA, Kontoyiannis D, Rolston K, Safdar A, Raad II, Chemaly RF. MRSA pneumonia in cancer patients: High failure rate with vancomycin. 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, Abstract #1649, 2007. e-Pub 2007.
- Adachi JA, Perego C, Hogan H, Vigil K, Youssef S, Pravinkumar E, St John C, Mulanovich V, Raad I, Chemaly R, Rolston K. Antibiotic stewardship initiative in the intensive care unit (ICU): Evidence from a quality improvement project supporting the development of a multidisciplinary antimicrobial stewardship team (MAST). 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, Abstract #1477, 2007. e-Pub 2007.
- Vigil KJ, Sheppard T, Adachi JA, del Busto R. High incidence of Clostridium difficile-associated diarrhea (CDAD) in hematopoietic stem cell transplant (HSCT) patients during 2005. 14th International Symposium on Infections in the Immunocompromised Host, Crans-Montana, Switzerland, 2006. e-Pub 2006.
- Adachi JA, Perego CA, Hogan HL, Vigil KJ, Youssef SS, Pravinkumar SE, St John CL, Raad II, Chemaly RF, Rolston KVI. Antibiotic stewardship initiative in the intensive care unit (ICU): Evidence from a quality improvement project supporting the development of a multidisciplinary antimicrobial stewardship team (MAST). UT-MDACC Division of Internal Medicine Research Retreat, Houston, TX, 2006. e-Pub 2006.
- Hogan HL, Adachi JA, Coyle EA, Rolston KVI. Daptomycin therapy of gram-positive infections (GPI) in pediatric cancer patients. 14th International Symposium of Infections in the Immunocompromised Host, Crans-Montana, Switzerland, 2006. e-Pub 2006.
- Rolston KVI, Row M, Hogan H, Adachi J, Pravinkumar S, Raad I. Antibiotic stewardship initiative at a comprehensive cancer center. 8th International Symposium on Febrile Neutropenia, Athens, Greece, 2006. e-Pub 2006.
- Souad Y, Hachem R, Chemaly R, Adachi JA, Jacobson K, Jiang Y, Rolston R, Safdar A, Kontoyiannis D, Raad II. Vitamin B6 was not affective for the prevention of hematologic toxicities of linezolid (LNZ) in cancer patients (Pts). 44th Annual Meeting of the Infectious Diseases Society of American, Toronto, Ontario, Canada, 2006. e-Pub 2006.
- Ghannam D, Rodriguez G, Adachi JA, Chemaly R, Rolston K, Raad I, Safdar A. Efficacy of inhaled aminoglycosides and colistin in cancer patients with ventilator-associated pneumonia during 2000-2005. 46th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2006. e-Pub 2006.
- Chemaly RF, Hachem R, Hanmod S, Adachi J, Hogan H, Kontoyiannis DP, Safdar A, Raad II, Rolston RVI. Clinical experience with Tigecycline in cancer patients: A report on 28 cases. 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Ontario, Canada, 2006. e-Pub 2006.
- Adachi JA, Graviss LS, Gonzalez VR, Perego CA, Hackett BJ, Dvorak TL, Chemaly RF, Raad II. Controlling multidrug resistant Pseudomonas aeruginosa (MDR-Psa) in critically ill cancer patients: The role of interventional molecular epidemiology. 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Chicago, IL, 2006. e-Pub 2006.
- Aboufaycal H, Adachi JA, Hachem R, Weiss LT, Kontoyiannis DP, Safdar A, Chemaly R, Rolston K, Raad I. Risk factors and outcome of infection with multidrug-resistant (MDR) Escherichia coli in patients with cancer. 43rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA, 2005. e-Pub 2005.
- Hogan H, Tarrand J, Adachi J, Hachem R, Graviss L, Perego C, Raad I, Chemaly R. Increase in enterococcal resistance to linezolid correlates with increase in linezolid usage: Collateral damage?. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 2005. e-Pub 2005.
- Aisenberg G, Adachi JA, Kontoyiannis DP, Dickey BF, Rolston K, Raad I, Safdar A. Stenotrophomonas maltophilia pneumonia (SmP) in 108 patients with cancer: Matched case-control analysis in 44 individuals with low-risk of infection, UT-MD Anderson Cancer Center. 1998-2004. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 2005. e-Pub 2005.
- Kumashi PA, Watson A, Adachi JA. An unusual case of cutaneous myiasis in a cancer patient. Internal Medicine and the Cancer Patient Conference, UT-MDACC, Houston, TX, 2004. e-Pub 2004.
- Adachi JA, Vigil KJ, Tarand J, Rolston K, Safdar A. Spectrum of non-Clostridium difficile bacterial enteric pathogens in hospitalized cancer patients with diarrhea during 1997-2004. 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2004. e-Pub 2004.
- Vigil KJ, Adachi JA, Carrillo C, Vigil CE, Zhi-Dong J, DuPont HL. Azithromycin is comparable to levofloxacin in the treatment of U.S. travelers with acute diarrhea in Lima, Peru. American College of Physicians, New Orleans, LA, 2004. e-Pub 2004.
- Vigil KJ, Adachi JA, Carrillo C, DuPont HL. Enteropathogenic E. coli (EPEC) as a cause of diarrhea in Peruvian adults in Lima, Peru, 2000-2004. 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2004. e-Pub 2004.
- Adachi JA, Yadegarinia D, Rolston K. Spectrum of polymicrobial bacterial Infection in patients with cancer, 1975-2002. American Society for Microbiology Conference on Polymicrobial Diseases, Lake Tahoe, NV, 2003. e-Pub 2003.
- Adachi JA, Ericsson CD, Jiang ZD, Martinez-Sandoval F, Knirsch C, DuPont HL. Azithromycin is comparable to levoloxacin in the treatment of U.S. travelers with acute diarrhea in Guadalajara, Mexico. 7th Conference of the International Society of Travel Medicine, Innsbruck, Austria, 2001. e-Pub 2001.
- Adachi JA, DuPont HL, DuPont MW, Ericsson CD. Knowledge of travelers’ diarrhea among 347 American college students visiting Guadalajara, Mexico, during the Summer of 1998. 7th Conference of the International Society of Travel Medicine, Innsbruck, Austria, 2001. e-Pub 2001.
- Huang DB, Jiang ZD, Ericsson CD, Adachi JA, DuPont HL. Emergence of resistant fecal flora in healthy persons during travel to Guadalajara, Mexico. 49th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Houston, TX, 2000. e-Pub 2000.
- Jiang ZD, Adachi JA, Li W, Ericsson CD, DuPont HL. Diarrheagenic Escherichia coli, blood antigen and secretor status. 49th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Houston, TX, 2000. e-Pub 2000.
Patient Reviews
CV information above last modified March 06, 2026